BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
51.79
-1.14 (-2.15%)
At close: May 29, 2026

SHA:688166 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,395961.06765.35998.051,180336.84
Trading Asset Securities
---50.6250.120.76
Cash & Short-Term Investments
1,395961.06765.351,0491,230337.6
Cash Growth
71.70%25.57%-27.02%-14.78%264.48%-35.02%
Accounts Receivable
388.73330.02339.5308.88307.47373.85
Other Receivables
3.289.136.6619.9118.783.75
Receivables
392.01339.14346.17328.79326.25377.59
Inventory
358.51364.25364.61344.63280.35200.06
Prepaid Expenses
---3.655.834.48
Other Current Assets
160.77124.04164.1411495.3973.27
Total Current Assets
2,3071,7891,6401,8401,938993.01
Property, Plant & Equipment
2,8022,7522,7052,4892,0761,378
Long-Term Investments
291.27671.08437.06425.86399.33348.28
Goodwill
--3.127.57.57.5
Other Intangible Assets
78.3979.5389.4893.6681.6480.84
Long-Term Accounts Receivable
-4.12.1---
Long-Term Deferred Tax Assets
111.3594.6862.242.2823.9419.86
Long-Term Deferred Charges
354.98339.1957.4930.1826.8725.83
Other Long-Term Assets
590.2795.42156.03104.09107.73115.86
Total Assets
6,5355,8255,1535,0324,6612,970
Accounts Payable
144.17185.89266228.18252.19211.89
Accrued Expenses
55.982.9772.0172.3169.0461.72
Short-Term Debt
68.93110.11115.26156.87124.38257.05
Current Portion of Long-Term Debt
-775.1516.96397.93313.8716.58
Current Portion of Leases
-8.8313.6916.11.349.87
Current Income Taxes Payable
-10.6116.6814.0414.973.69
Current Unearned Revenue
31.7325.5628.022429.4920.33
Other Current Liabilities
690.5381.2323.7612.816.261.93
Total Current Liabilities
991.271,2801,052922.25811.52583.07
Long-Term Debt
2,3351,4901,5801,6151,576618.69
Long-Term Leases
2610.2110.2121.016.010.22
Long-Term Unearned Revenue
65.29167.5884.7126.252626
Other Long-Term Liabilities
216.1130.3-29.82--
Total Liabilities
3,6332,9792,7272,6142,4201,228
Common Stock
423.1423.1422.47422.47422.47410
Additional Paid-In Capital
1,0761,076982.361,0571,008738.94
Retained Earnings
1,0761,0661,046897.66743.35555.05
Treasury Stock
-20.05-20.05-10.01---
Comprehensive Income & Other
-24.54-24.21-57.82-8.6417.77-25.8
Total Common Equity
2,5302,5212,3832,3692,1921,678
Minority Interest
371.26325.0142.7348.9750.0463.45
Shareholders' Equity
2,9022,8462,4262,4182,2421,742
Total Liabilities & Equity
6,5355,8255,1535,0324,6612,970
Total Debt
2,4302,3952,2362,2072,022902.42
Net Cash (Debt)
-1,034-1,433-1,470-1,158-791.15-564.82
Net Cash Per Share
-2.42-3.42-3.50-2.75-1.91-1.39
Filing Date Shares Outstanding
464.69422.54422.11422.1422.47410
Total Common Shares Outstanding
464.69422.54422.11422.47422.47410
Working Capital
1,315508.2587.89917.491,127409.94
Book Value Per Share
5.455.975.655.615.194.09
Tangible Book Value
2,4522,4422,2912,2672,1031,590
Tangible Book Value Per Share
5.285.785.435.374.983.88
Buildings
-745.28728.65261.26273.4104.72
Machinery
-1,2711,122704.8318.41287.37
Construction In Progress
-1,1871,1671,7361,6661,131